Cargando…

Molecular distinctions among ERBB2-overexpressing breast cancers

Detalles Bibliográficos
Autor principal:	Jeffrey, SS
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233486/ http://dx.doi.org/10.1186/bcr1065

Ejemplares similares

The ErbB receptor tyrosine kinases and their roles in cancer
por: Hynes, NE
Publicado: (2003)

Synergy between the erbB and transforming growth factor beta signaling networks: implications for molecular therapeutics in human neoplasia
por: Arteaga, CL
Publicado: (2003)

DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status
por: Flanagan, JM, et al.
Publicado: (2010)

Molecular heterogeneity of luminal breast cancer
por: Loi, S
Publicado: (2011)

Two molecular cytogenetic views of breast cancer
por: Gray, J, et al.
Publicado: (2000)

Characterization, isolation and cultivation of distinctive human breast cell populations
por: Villadsen, R, et al.
Publicado: (2003)

Gene amplification in breast cancer – looking for the molecular mechanisms
por: Kovalenko, Sergei
Publicado: (2010)

Activation of the ErbB3-AKT axis promotes melanoma cell survival and proliferation in response to RAF/MEK inhibition
por: Fattore, Luigi, et al.
Publicado: (2014)

CDH3/P-cadherin overexpression in breast carcinomas: its regulatory mechanisms, the role in cell invasion, and the association with cancer stem cell properties
por: Paredes, Joana
Publicado: (2010)

Molecular approaches to understanding pregnancy-induced protection against breast cancer
por: Blakely, CM, et al.
Publicado: (2005)

Molecular profiling of early breast cancer in relation to detection of micrometastases and outcome
por: Naume, B, et al.
Publicado: (2005)

Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design
por: Pusztai, L
Publicado: (2009)

Molecular control of apoptosis in the breast
por: Streuli, C, et al.
Publicado: (2000)

The challenges in translating present knowledge of the molecular biology of breast cancer into clinical use
por: Davidson, N
Publicado: (2005)

A10 OVEREXPRESSION OF ASCL2 ALTERS DIFFERENTIATION, CELL CYCLE AND RESISTANCE TO ANTI-CANCER TREATMENT IN ESOPHAGEAL ORGANOIDS
por: Hamilton, M, et al.
Publicado: (2023)

Molecular characteristics of inherited breast tumors
por: Borg, Å, et al.
Publicado: (2000)

Gene pathways associated with prognosis and chemotherapy sensitivity in different molecular subtypes of breast cancer
por: Pusztai, L
Publicado: (2011)

Gene expression profiles and molecular classification to predict distant metastasis and tamoxifen-resistant breast cancer
por: Klijn, JGM, et al.
Publicado: (2005)

Adjuvant therapy of HER2(+ )breast cancer
por: Winer, EP
Publicado: (2009)

Cancer susceptibility in ATM heterozygotes: do two distinct carrier populations exist?
por: Gatti, RA, et al.
Publicado: (2000)

Targeting HER2 in breast cancer: beyond trastuzumab
por: Winer, EP
Publicado: (2011)

Translational breast cancer research in luminal breast cancer
por: Dowsett, M
Publicado: (2011)

Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers
por: Vernimmen, D, et al.
Publicado: (2003)

56. BREAKING BARRIERS TO BREAST RECONSTRUCTION AMONG SOCIOECONOMICALLY DISADVANTAGED BREAST CANCER PATIENTS: LESSONS LEARNED AT A LARGE SAFETY-NET HOSPITAL
por: Meade, Anna, et al.
Publicado: (2022)

Epigenetics of breast cancer
por: Esteller, M
Publicado: (2011)

Stem cells in normal breast development and breast cancer
por: Wicha, MS, et al.
Publicado: (2003)

Long-term survival of interval breast cancers in breast cancer screening in Wales
por: Fong, YF, et al.
Publicado: (2012)

Distinct activities of HTLV-1 Tax1 from HTLV-2 Tax2 play key roles in pathogenesis
por: Fujii, Masahiro, et al.
Publicado: (2011)

Fulvestrant-induced expression of erbB3 and erbB4 sensitizes ER-positive breast cancer cells to heregulins
por: Hutcheson, IR, et al.
Publicado: (2010)

Asthmatic children that are uncontrolled despite inhaled corticosteroids have a distinct breathprint (the pacman2 study)
por: Vijverberg, Susanne, et al.
Publicado: (2015)

Regulation of recombinational repair by the familial breast cancer susceptibility protein BRCA2
por: West, SC, et al.
Publicado: (2006)

Distinctive personality patterns in patients with chronic viral hepatitis
por: Cercel, Ioana-Catrinel, et al.
Publicado: (2014)

The future of breast cancer prevention
por: Howell, A, et al.
Publicado: (2005)

Genomic profiling of breast cancer
por: Borg, Å
Publicado: (2005)

Update on breast cancer genetics
por: Izatt, L
Publicado: (2006)

Clinical breast cancer and estrogen
por: Chew, HK
Publicado: (2003)

Predictive factors in breast cancer
por: Klijn, J, et al.
Publicado: (2000)

Immunity and autoimmunity in breast cancer
por: Curigliano, G
Publicado: (2011)

Overexpression of walldof transcription factor increases secondary wall deposition and alters carbon partitioning in poplar
por: Gerhardt, Isabel R, et al.
Publicado: (2011)

Is ultrasound axillary staging less accurate in invasive lobular breast cancer than in ductal breast cancer?
por: Sankaye, P, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0plti6mre4tgd3i1njl1bl64ga